Literature DB >> 3884309

[Cisplatin in ovarian cancer: how much and how long?].

G E Umbach, H von Matthiessen, P Faber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884309     DOI: 10.1055/s-2008-1068849

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  1 in total

1.  Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.

Authors:  W Jäger; R Adam; L Wildt; N Lang
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.